Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Kairos Pharma, Ltd. (KAPA) Stock-Based Compensation data is not available.
| Income Statement Financials | |
-- |
|
$-5.45M |
|
-- |
|
-- |
|
$5.57M |
|
$-5.57M |
|
$0.12M |
|
$-5.45M |
|
$-5.45M |
|
$-5.45M |
|
$-5.45M |
|
$-5.45M |
|
$-5.45M |
|
$-5.57M |
|
$-3.24M |
|
18.43M |
|
18.43M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$5.39M |
|
-- |
|
$1.15M |
|
$6.54M |
|
$0.20M |
|
-- |
|
-- |
|
$0.20M |
|
$6.34M |
|
$6.28M |
|
$6.34M |
|
20.82M |
|
| Cash Flow Statement Financials | |
$-3.44M |
|
-- |
|
$6.66M |
|
$1.27M |
|
$4.49M |
|
$3.22M |
|
|
Stock-Based Compensation |
-- |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
27.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.44M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-85.90% |
|
-86.75% |
|
-83.29% |
|
-85.90% |
|
$0.30 |
|
$-0.19 |
|
$-0.19 |
|